Stephen D. Cary

SVP, Business Development & Chief Operating Officer at Handa Pharmaceuticals

Mr. Cary has over 20 years of sales, marketing, and business development experience in branded and generic pharmaceutical products and medical devices. Prior to joining Handa, he served as Executive Vice President of Business Development and Co-founder of Cary Pharmaceuticals Inc., a specialty pharmaceutical company based in the Washington, DC area. From 1992-1999, Mr. Cary held various sales and marketing roles at Glaxo Inc. (now GlaxoSmithKline) and was involved in the product launches and line extensions of several key growth products (CeftinR, ImitrexR, SereventR, ZantacR, ZofranR, and ZybanR) for the hospital and retail markets, across multiple therapeutic areas including addiction medicine, anti-infectives, CNS, gastrointestinal, and respiratory.

Mr. Cary received a B.B.A. degree in Marketing from the University of Iowa in 1992 and an M.B.A. degree in Management and Entrepreneurship from the University of Maryland in 1999.